- Home
- TILE vs IMCR Comparison
TILE vs IMCR Comparison
Compare TILE & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TILE
- IMCR
- Stock Information
- Founded
- TILE 1973
- IMCR 2008
- Country
- TILE United States
- IMCR United Kingdom
- Employees
- TILE N/A
- IMCR N/A
- Industry
- TILE Home Furnishings
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TILE Consumer Discretionary
- IMCR Health Care
- Exchange
- TILE Nasdaq
- IMCR Nasdaq
- Market Cap
- TILE 1.3B
- IMCR 1.5B
- IPO Year
- TILE N/A
- IMCR 2021
- Fundamental
- Price
- TILE $21.48
- IMCR $29.92
- Analyst Decision
- TILE Buy
- IMCR Buy
- Analyst Count
- TILE 2
- IMCR 13
- Target Price
- TILE $22.00
- IMCR $65.18
- AVG Volume (30 Days)
- TILE 416.8K
- IMCR 158.6K
- Earning Date
- TILE 02-25-2025
- IMCR 02-26-2025
- Dividend Yield
- TILE 0.19%
- IMCR N/A
- EPS Growth
- TILE 11277.07
- IMCR N/A
- EPS
- TILE 1.44
- IMCR N/A
- Revenue
- TILE $1,305,766,000.00
- IMCR $296,312,000.00
- Revenue This Year
- TILE $6.86
- IMCR $28.89
- Revenue Next Year
- TILE $3.56
- IMCR $13.00
- P/E Ratio
- TILE $14.86
- IMCR N/A
- Revenue Growth
- TILE 2.66
- IMCR 25.09
- 52 Week Low
- TILE $13.07
- IMCR $27.69
- 52 Week High
- TILE $27.34
- IMCR $72.56
- Technical
- Relative Strength Index (RSI)
- TILE 30.83
- IMCR 47.96
- Support Level
- TILE $22.05
- IMCR $28.41
- Resistance Level
- TILE $23.44
- IMCR $30.49
- Average True Range (ATR)
- TILE 0.61
- IMCR 1.47
- MACD
- TILE -0.14
- IMCR -0.07
- Stochastic Oscillator
- TILE 7.58
- IMCR 41.03
About TILE Interface Inc.
Interface Inc is engaged in the design, production, and sale of carpet tiles. It also provides Luxury Vinyl tiles and rubber flooring. The company mainly targets corporate and noncorporate office markets, including government, education, healthcare, hospitality, and retailers. Its geographical segments include the Americas, Europe, and Asia-Pacific. It has two operating and reportable segments - AMS and EAAA.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.